Company Filing History:

11 out of 4,770

Merck + Co., Inc.

patents

1 out of 2,405

Merck Sharp + Dohme Corp.

patents

1 out of 3

Merck Sharp & Dohme De Espana Sa

patents

where one patent can have more than one assignee

Years Active: 1983-2015

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9126983 - Extracts from kibdelos porangium as antibacterial agents (2015-09-08),

2. 7294646 - Maxi-k channel blockers, methods of use and process for making the same (2007-11-13),

3. 5861375 - Antiprotozoal cyclic tetrapeptides (1999-01-19),

4. 5631282 - Triterpenes (1997-05-20),

5. 5620953 - Antiprotozoal cyclic tetrapeptides (1997-04-15),

6. 5352800 - Process for the production of a novel endothelin antagonist (1994-10-04),

7. 5276054 - Substituted hexahydrobenzopyran derivatives as angiotensin II antagonists (1994-01-04),

8. 5095003 - Oxytocin and vasopressin antagonists (1992-03-10),

9. 4696925 - Cholecystokinin antagonist compounds (1987-09-29),

10. 4695544 - Process for the preparation of cholecystokinin antagonists (1987-09-22),

11. 4530790 - Cholecystokinin antagonists (1985-07-23),

12. 4390546 - Antiparasitic macrolide from a strain of Streptomyces hygroscopicus (1983-06-28),

Title: Innovations of Michael A Goetz in Antibacterial Agents and Neuroprotective Compounds

Introduction

Michael A Goetz, based in Fanwood, NJ, is a prolific inventor with a remarkable portfolio consisting of 12 patents. He has significantly contributed to the fields of medicine and pharmacology, particularly focusing on antibacterial agents and treatments for conditions related to elevated intraocular pressure.

Latest Patents

Among his latest innovations are two noteworthy patents. The first, titled "Extracts from Kibdelos porangium as Antibacterial Agents," relates to novel compounds that play a crucial role in the treatment and prevention of bacterial infections in both humans and animals. This patent details various methods for inhibiting bacterial growth and describes biologically pure cultures that can produce these compounds.

The second patent, "Maxi-K Channel Blockers, Methods of Use and Process for Making the Same," addresses the formulation of potent potassium channel blockers for treating glaucoma and other related conditions. This invention not only offers solutions for managing elevated intraocular pressure but also aims to provide neuroprotective effects to the eyes of mammalian species, particularly humans.

Career Highlights

Michael A Goetz's career has been marked by significant contributions to renowned companies, including Merck & Company, Inc., and Merck Sharp & Dohme Corporation. His work at these organizations has paved the way for advancements in pharmaceutical technologies and therapeutic applications, especially concerning antibacterial and ocular health.

Collaborations

Throughout his career, Michael has collaborated with notable professionals, including Sheo B Singh and Richard L Monaghan. These collaborations have not only enriched his inventions but have also played a pivotal role in scientific advancements in their respective fields.

Conclusion

Michael A Goetz stands out as an influential inventor whose work continues to impact healthcare significantly. With his innovative patents focusing on critical areas such as antibacterial treatments and eye health, he remains a cornerstone in the evolving landscape of medical science. His dedication and contributions underscore the importance of innovation in addressing some of the most pressing health challenges of our time.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.